Search Results - "Rosas Plaza, Ximena"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy by Rosas Plaza, Ximena, van Agthoven, Ton, Meijer, Coby, van Vugt, Marcel A T M, de Jong, Steven, Gietema, Jourik A, Looijenga, Leendert H J

    Published in Cells (Basel, Switzerland) (08-10-2019)
    “…LDH (lactate dehydrogenase), AFP (alpha-fetoprotein) and β-HCG (human chorionic gonadotropin) are used in diagnosis and follow-up of testicular germ cell…”
    Get full text
    Journal Article
  2. 2

    Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities by de Vries, Gerda, Rosas-Plaza, Ximena, van Vugt, Marcel A.T.M., Gietema, Jourik A., de Jong, Steven

    Published in Cancer treatment reviews (01-08-2020)
    “…•Testicular cancers are characterized by insufficient DNA repair and a hypersensitive apoptotic response, resulting in a high sensitivity to cisplatin-based…”
    Get full text
    Journal Article
  3. 3

    Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment by Rosas-Plaza, Ximena, de Vries, Gerda, Meersma, Gert Jan, Suurmeijer, Albert J H, Gietema, Jourik A, van Vugt, Marcel A T M, de Jong, Steven

    Published in Molecular cancer therapeutics (01-02-2020)
    “…Testicular cancer is the most common cancer type among young men. Despite highly effective cisplatin-based chemotherapy, around 20% of patients with metastatic…”
    Get full text
    Journal Article
  4. 4

    Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities by Fontana, Elisa, Arkenau, Hendrik-Tobias

    Published in Cancer treatment reviews (01-08-2020)
    “…•The COVID-19 pandemic affected clinical trial recruitment and management.•A series of measures were rapidly put in place to reduce the risk of exposure to the…”
    Get full text
    Journal Article
  5. 5

    Abstract 3861: Development of testicular cancer patient derived xenograft models to test combination therapies targeting PI3K/Akt and MDM2 by Vries, Gerda de, Rosas-Plaza, Ximena, Vugt, Marcel A. van, Suurmeijer, Albert J.H., Gietema, Jourik A., Jong, Steven de

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Metastatic testicular cancer (TC) is highly sensitive to cisplatin-based chemotherapy. However, patients with advanced disease in the poor prognosis…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abstract 152: Dual mTORC1/2 inhibition sensitizes testicular cancer cell lines toward cisplatin treatment by Plaza, Fernanda Ximena Rosas, Vries, Gerda de, Suurmeijer, Albert J., Gietema, Jourik A., Vugt, Marcel A.T.M. van, Jong, Steven de

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Testicular cancer (TC) patients with metastatic disease and poor prognosis have a 50% 5-year survival. It has been reported that resistant TC cell…”
    Get full text
    Journal Article
  8. 8

    Experimentally‐Induced Melanoma has an Heterogeneous Oxidative Metabolism and Induces Peri‐Tumoral Innervation Remodeling by Noriega‐Cisneros, Ruth, RosasPlaza, F. Ximena, Ramírez‐Santos, Jesús, Gutierrez‐Ospina, Gabriel

    Published in The FASEB journal (01-04-2016)
    “…Abstract only Conventional wisdom assumes that carcinogenesis is caused by mutations in genes involved in the control of cell proliferation and survival,…”
    Get full text
    Journal Article